Antibiotics vs steroids for granulomatous lobular mastitis
Part of Skin, Women’s health & pregnancy clinical trials.
This study compares two common treatments—antibiotics and steroids—to see which works better for a rare breast inflammation condition called granulomatous lobular mastitis (GLM). It aims to find the most effective and safe option for women with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman diagnosed with granulomatous lobular mastitis (GLM) confirmed by a biopsy
- You are willing to take part in the study and come for follow-up visits
- You are not pregnant or breastfeeding
- You are not already taking antibiotics or steroids that are working for GLM
- You do not have a weakened immune system, uncontrolled diabetes, or an allergy to the study medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at different ways to treat granulomatous lobular mastitis (GLM), a type of breast inflammation that is not an infection. The goal is to find which treatment works best for people with this condition.
This trial tests tocilizumab, a medication that reduces inflammation, for granulomatous lobular mastitis (GLM)—a rare, persistent breast inflammation. If your GLM hasn't responded to steroid therapy or you can't tolerate steroids, this study may help reduce inflammation and symptoms.
This study compares different surgical methods for treating granulomatous mastitis, a rare inflammatory breast condition. It aims to find which approach works best for patients who can safely have surgery.
This study is creating a registry (a database) for people with a rare inflammatory breast condition called granulomatous mastitis. It aims to learn more about the disease and how it affects people, without testing any new treatments.
This trial compares two treatments—steroids (prednisolone) and methotrexate—for a chronic inflammatory breast condition. It aims to find which option works better with fewer side effects.
This study looks at surgical treatment for granulomatous lobular mastitis that has not been improving with non-surgical care. It may help people with more widespread or complicated breast inflammation, especially when there are abscesses or skin breakdown.
Hear when a new Granulomatous Mastitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.